Lv7
3300 积分 2024-02-12 加入
The American Neurogastroenterology and Motility Society Gastroparesis Cardinal Symptom Index‐Daily Diary (ANMS GCSI‐DD): Psychometric validation and meaningful change threshold in patients with idiopathic or diabetic gastroparesis
5天前
已完结
Gastrointestinal effects of GLP-1 receptor agonists: mechanisms, management, and future directions
29天前
已完结
RATES OF REPEAT EGD IN NON-DIABETIC ADULTS WITH GLUCAGON-LIKE-PEPTIDE- 1 RECEPTOR AGONIST PRESCRIPTION: A RETROSPECTIVE MATCHED COHORT STUDY
1个月前
已完结
PPAR-γ agonist pioglitazone and the risks of malignancy among type2 diabetes mellitus patients
1个月前
已完结
Vagus Nerve and Gut-Brain Communication
1个月前
已完结
Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action
1个月前
已完结
Definite benefits of GLP-1 receptor agonists: what is the risk of gastroparesis and lung aspiration?
3个月前
已完结
What is the pipeline for future medications for obesity?
3个月前
已完结
Pharmacologic management of obesity: Updates on approved medications, indications and risks
4个月前
已完结
Quantified Metrics of Gastric Emptying Delay by GLP-1 Agonists: A Systematic Review and Meta-Analysis with Insights for Periprocedural Management
4个月前
已关闭
皖公网安备34019202002308
